Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03422471 · ClinicalTrials.gov registry record · NA
Hypoglycemia and Autonomic Nervous System Function- B2
A NA study of Hypoglycemia and Type2 Diabetes, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT03422471 is a NA study of Hypoglycemia and Type2 Diabetes that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 14 participants, below the 506-participant average among 40 other Hypoglycemia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03422471, a NA study of Hypoglycemia and Type2 Diabetes, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
We will study the effect of hypoglycemia (low blood sugar) on baroreflex sensitivity in participants with well controlled type 2 diabetes.
Conditions Studied
Interventions
- OTHER Hyperinsulinemic Hypoglycemic Clamp
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-09-25 |
| Est. Completion | 2025-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03422471
The ClinicalTrials.gov registry entry for NCT03422471 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 506-participant average among 40 other Hypoglycemia trials with a reported enrollment target (97% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypoglycemia appearing as the primary indexed condition, and to 1 intervention - of which Hyperinsulinemic Hypoglycemic Clamp is the first listed.
NCT03422471 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03422471 about?
NCT03422471 is a clinical study titled "Hypoglycemia and Autonomic Nervous System Function- B2". We will study the effect of hypoglycemia (low blood sugar) on baroreflex sensitivity in participants with well controlled type 2 diabetes.
What is the current status of trial NCT03422471?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2017-09-25. Estimated completion is 2025-11-25.
What conditions does trial NCT03422471 study?
This clinical trial studies the following conditions: Hypoglycemia, Type2 Diabetes.
What interventions are being tested in trial NCT03422471?
The interventions under investigation include: Hyperinsulinemic Hypoglycemic Clamp (OTHER).
Who is sponsoring clinical trial NCT03422471?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03422471 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes
RECRUITING · NA
-
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
RECRUITING · NA
-
Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation
RECRUITING · NA
-
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
RECRUITING · NA
-
Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.